236 related articles for article (PubMed ID: 32567429)
1. Tumor necrosis factor ligand-related molecule 1A affects the intestinal mucosal barrier function by promoting Th9/interleukin-9 expression.
Zhao C; Wang D; Wu M; Luo Y; Yang M; Guo J; Zhang H; Zhang X
J Int Med Res; 2020 Jun; 48(6):300060520926011. PubMed ID: 32567429
[TBL] [Abstract][Full Text] [Related]
2. Effects and Mechanism of Constitutive TL1A Expression on Intestinal Mucosal Barrier in DSS-Induced Colitis.
Yang M; Jia W; Wang D; Han F; Niu W; Zhang H; Shih DQ; Zhang X
Dig Dis Sci; 2019 Jul; 64(7):1844-1856. PubMed ID: 30949903
[TBL] [Abstract][Full Text] [Related]
3. TL1A modulates the severity of colitis by promoting Th9 differentiation and IL-9 secretion.
Wang D; Li H; Duan YY; Han F; Luo YX; Wu MY; Yang MY; Zhan RR; Song J; Zhang H; Zhang XL
Life Sci; 2019 Aug; 231():116536. PubMed ID: 31176785
[TBL] [Abstract][Full Text] [Related]
4. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation.
Takedatsu H; Michelsen KS; Wei B; Landers CJ; Thomas LS; Dhall D; Braun J; Targan SR
Gastroenterology; 2008 Aug; 135(2):552-67. PubMed ID: 18598698
[TBL] [Abstract][Full Text] [Related]
5. The effects and mechanisms of myeloid differentiation protein 2 on intestinal mucosal permeability in mice with chronic colitis.
Han C; Guan Q; Guo L; Yang Y; Ruan S; Zhang X
J Cell Physiol; 2019 Nov; 234(11):21089-21099. PubMed ID: 31032920
[TBL] [Abstract][Full Text] [Related]
6. Tumor Necrosis Factor Ligand-Related Molecule 1A Regulates the Occurrence of Colitis-Associated Colorectal Cancer.
Niu W; Wu Z; Wang J; Zhang H; Jia W; Yang M; Luo Y; Zhang X
Dig Dis Sci; 2018 Sep; 63(9):2341-2350. PubMed ID: 29796912
[TBL] [Abstract][Full Text] [Related]
7. Constitutive TL1A expression under colitogenic conditions modulates the severity and location of gut mucosal inflammation and induces fibrostenosis.
Barrett R; Zhang X; Koon HW; Vu M; Chang JY; Yeager N; Nguyen MA; Michelsen KS; Berel D; Pothoulakis C; Targan SR; Shih DQ
Am J Pathol; 2012 Feb; 180(2):636-49. PubMed ID: 22138299
[TBL] [Abstract][Full Text] [Related]
8. Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis.
Castellanos JG; Woo V; Viladomiu M; Putzel G; Lima S; Diehl GE; Marderstein AR; Gandara J; Perez AR; Withers DR; Targan SR; Shih DQ; Scherl EJ; Longman RS
Immunity; 2018 Dec; 49(6):1077-1089.e5. PubMed ID: 30552020
[TBL] [Abstract][Full Text] [Related]
9. TL1A primed dendritic cells activation exacerbated chronic murine colitis.
Han F; Song J; Jia W; Yang M; Wang D; Zhang H; Shih DQ; Targan SR; Zhang X
Life Sci; 2020 Dec; 262():118220. PubMed ID: 32781075
[TBL] [Abstract][Full Text] [Related]
10. Effect and Mechanism of TL1A Expression on Epithelial-Mesenchymal Transition during Chronic Colitis-Related Intestinal Fibrosis.
Wenxiu J; Mingyue Y; Fei H; Yuxin L; Mengyao W; Chenyang L; Jia S; Hong Z; Shih DQ; Targan SR; Xiaolan Z
Mediators Inflamm; 2021; 2021():5927064. PubMed ID: 34257516
[TBL] [Abstract][Full Text] [Related]
11. Dahuang Mudan decoction repairs intestinal barrier in chronic colitic mice by regulating the function of ILC3.
Huang S; Wang X; Xie X; Su Y; Pan Z; Li Y; Liang J; Zhang M; Pan S; Xu B; Li L; Chen J; Luo X; Zhou L
J Ethnopharmacol; 2022 Dec; 299():115652. PubMed ID: 36038092
[TBL] [Abstract][Full Text] [Related]
12. TL1A blocking ameliorates intestinal fibrosis in the T cell transfer model of chronic colitis in mice.
Li H; Song J; Niu G; Zhang H; Guo J; Shih DQ; Targan SR; Zhang X
Pathol Res Pract; 2018 Feb; 214(2):217-227. PubMed ID: 29254800
[TBL] [Abstract][Full Text] [Related]
13. A high salt diet protects interleukin 10-deficient mice against chronic colitis by improving the mucosal barrier function.
Wang D; Jin H; Sheng J; Cheng L; Lin Q; Lazerev M; Jin P; Li X
Mol Immunol; 2022 Oct; 150():39-46. PubMed ID: 35944464
[TBL] [Abstract][Full Text] [Related]
14. Aureusidin derivative CNQX inhibits chronic colitis inflammation and mucosal barrier damage by targeting myeloid differentiation 2 protein.
Yang Y; Sheng Y; Wang J; Zhou X; Guan Q; Shen H; Li W; Ruan S
J Cell Mol Med; 2021 Aug; 25(15):7257-7269. PubMed ID: 34184406
[TBL] [Abstract][Full Text] [Related]
15. Chloride channel ClC-2 is a key factor in the development of DSS-induced murine colitis.
Nighot P; Young K; Nighot M; Rawat M; Sung EJ; Maharshak N; Plevy SE; Ma T; Blikslager A
Inflamm Bowel Dis; 2013 Dec; 19(13):2867-77. PubMed ID: 24030525
[TBL] [Abstract][Full Text] [Related]
16. Syndecan-1 Acts in Synergy with Tight Junction Through Stat3 Signaling to Maintain Intestinal Mucosal Barrier and Prevent Bacterial Translocation.
Wang Z; Li R; Tan J; Peng L; Wang P; Liu J; Xiong H; Jiang B; Chen Y
Inflamm Bowel Dis; 2015 Aug; 21(8):1894-907. PubMed ID: 25970544
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol alleviates intestinal mucosal barrier dysfunction in dextran sulfate sodium-induced colitis mice by enhancing autophagy.
Pan HH; Zhou XX; Ma YY; Pan WS; Zhao F; Yu MS; Liu JQ
World J Gastroenterol; 2020 Sep; 26(33):4945-4959. PubMed ID: 32952341
[TBL] [Abstract][Full Text] [Related]
18. Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK/pMLC2 pathway.
Huang S; Fu Y; Xu B; Liu C; Wang Q; Luo S; Nong F; Wang X; Huang S; Chen J; Zhou L; Luo X
Phytomedicine; 2020 Mar; 68():153179. PubMed ID: 32062328
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of Saccharomyces boulardii on intestinal mucosal barrier of dextran sodium sulfate-induced colitis in mice.
Dong JP; Zheng Y; Wu T; He Q; Teng GG; Wang HH
Chin Med J (Engl); 2019 Aug; 132(16):1951-1958. PubMed ID: 31335471
[TBL] [Abstract][Full Text] [Related]
20. Nobiletin Attenuates DSS-Induced Intestinal Barrier Damage through the HNF4α-Claudin-7 Signaling Pathway.
Wen X; Zhao H; Wang L; Wang L; Du G; Guan W; Liu J; Cao X; Jiang X; Tian J; Wang M; Ho CT; Li S
J Agric Food Chem; 2020 Apr; 68(16):4641-4649. PubMed ID: 32249565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
